|
Status |
Public on Nov 03, 2022 |
Title |
1 Vehicle |
Sample type |
SRA |
|
|
Source name |
Human Primary Periphheral Blood B Cells
|
Organism |
Homo sapiens |
Characteristics |
cell type: B cells activating antibody: Vehicle treatment: 8 hours incubation
|
Treatment protocol |
anti-CD74 activating antibody was added to 10^7 cells for 1 hour. Then samples 1 Vehicle, 1 CD74 activated, 2 Vehicle and 2 CD74 activated underwent IP with anti-H3K4me2 antibody (ab-32356 ).
|
Growth protocol |
Primary B cells were isolated from freshly received blood donations.
|
Extracted molecule |
genomic DNA |
Extraction protocol |
In-house ChIP-Seq protocol, Libraries were evaluated by Qubit and TapeStation. Sequencing libraries were constructed with barcodes to allow multiplexing of y samples on one lane.
|
|
|
Library strategy |
ChIP-Seq |
Library source |
genomic |
Library selection |
ChIP |
Instrument model |
Illumina NextSeq 500 |
|
|
Description |
1_H3_Ctrl
|
Data processing |
Reads were demultiplexed Adapters were trimmed using the cutadapt tool The reads were aligned uniquely to the human genome (hg19) Bound regions were detected using MACS2 Genome_build: hg19 Supplementary_files_format_and_content: bed files of MACS2 peaks
|
|
|
Submission date |
Aug 09, 2021 |
Last update date |
Nov 03, 2022 |
Contact name |
Idit Shachar |
Organization name |
Weizmann Institute
|
Street address |
234 Herzl Street
|
City |
Rehovot |
ZIP/Postal code |
POB 26 7610001 |
Country |
Israel |
|
|
Platform ID |
GPL18573 |
Series (2) |
GSE181676 |
Genome wide H3K4me2 detection after CD74 activation. |
GSE181677 |
B cells after CD74 activation. |
|
Relations |
BioSample |
SAMN20669181 |
SRA |
SRX11675273 |